Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03145558
Title TATE Versus TACE in Intermediate Stage HCC (TATE)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Teclison Ltd.
Indications

hepatocellular carcinoma

Therapies

Doxorubicin

Tirapazamine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.